Trial Profile
A Single Center Randomized Controlled Trial of the Efficacy and Safety of PEG-rhG-CSF After Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2022
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary) ; Filgrastim
- Indications Neutropenia
- Focus Therapeutic Use
- 30 Sep 2016 New trial record